Brief: Kang Stem Biotech receives Australia patent
16/10/2017 09:12
Oct 16 (Reuters) - Kang Stem Biotech Co Ltd 217730.KQ :
* Says it received Australia patent on Oct. 16, for method
of preparing induced neural stem cells reprogrammed from
non-neuronal cells using hmga2
Source text in Korean: https://goo.gl/TyMJhw
Further company coverage: 217730.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Kang Stem Biotech
See all newsBrief: Kangstem Biotech To Conduct Capital Increase Of 49 Billion Won
Brief: Kangstem Biotech To Conduct Capital Increase Of 35.7 Billion Won
Brief: Kang Stem Biotech to invest 8.76 bln won in facilities extension
Brief: Kang Stem Biotech receives patent
Brief: Kang Stem Biotech raises 35.95 bln won via rights issue